Literature DB >> 19381954

Quantitative, fluorescence-based in-situ assessment of protein expression.

Christopher B Moeder1, Jennifer M Giltnane, Sharon Pozner Moulis, David L Rimm.   

Abstract

As companion diagnostics grow in prevalence and importance, the need for accurate assessment of in situ protein concentrations has increased. Traditional immunohistochemistry (IHC), while valuable for assessment of context of expression, is less valuable for quantification. The lack of rigorous quantitative potential of traditional IHC led to our development of an immunofluorescence-based method now commercialized as the AQUA technology. Immunostaining of tissue samples, image acquisition, and use of AQUA software allow investigators to quickly, efficiently, and accurately measure levels of expression within user-defined subcellular or architectural compartments. IHC analyzed by AQUA shows high reproducibility and demonstrates protein measurement accuracy similar to ELISA assays. The process is largely automated, eliminating potential error, and the resultant scores are exported on a continuous scale. There are now numerous published examples where observations made with this technology are not seen by traditional methods.

Mesh:

Substances:

Year:  2009        PMID: 19381954     DOI: 10.1007/978-1-60327-811-9_12

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  22 in total

Review 1.  Aurora kinases in head and neck cancer.

Authors:  Ranee Mehra; Ilya G Serebriiskii; Barbara Burtness; Igor Astsaturov; Erica A Golemis
Journal:  Lancet Oncol       Date:  2013-09       Impact factor: 41.316

2.  Gefitinib or placebo in combination with tamoxifen in patients with hormone receptor-positive metastatic breast cancer: a randomized phase II study.

Authors:  C Kent Osborne; Patrick Neven; Luc Y Dirix; John R Mackey; Jean Robert; Craig Underhill; Rachel Schiff; Carolina Gutierrez; Ilenia Migliaccio; Valsamo K Anagnostou; David L Rimm; Patrick Magill; Mark Sellers
Journal:  Clin Cancer Res       Date:  2011-01-10       Impact factor: 12.531

Review 3.  Construction and analysis of multiparameter prognostic models for melanoma outcome.

Authors:  Bonnie E Gould Rothberg; David L Rimm
Journal:  Methods Mol Biol       Date:  2014

4.  PD-L1 Expression Correlates with Tumor-Infiltrating Lymphocytes and Response to Neoadjuvant Chemotherapy in Breast Cancer.

Authors:  Hallie Wimberly; Jason R Brown; Kurt Schalper; Herbert Haack; Matthew R Silver; Christian Nixon; Veerle Bossuyt; Lajos Pusztai; Donald R Lannin; David L Rimm
Journal:  Cancer Immunol Res       Date:  2014-12-19       Impact factor: 11.151

5.  Subcellular localization of p27 and prostate cancer recurrence: automated digital microscopy analysis of tissue microarrays.

Authors:  Viju Ananthanarayanan; Ryan J Deaton; Anup Amatya; Virgilia Macias; Ed Luther; Andre Kajdacsy-Balla; Peter H Gann
Journal:  Hum Pathol       Date:  2011-02-02       Impact factor: 3.466

6.  Lin28 regulates BMP4 and functions with Oct4 to affect ovarian tumor microenvironment.

Authors:  Wei Ma; Jing Ma; Jie Xu; Chong Qiao; Adam Branscum; Andres Cardenas; Andre T Baron; Peter Schwartz; Nita J Maihle; Yingqun Huang
Journal:  Cell Cycle       Date:  2012-12-19       Impact factor: 4.534

7.  Macrophage expression of tartrate-resistant acid phosphatase as a prognostic indicator in colon cancer.

Authors:  Joan How; Jason R Brown; Sasha Saylor; David L Rimm
Journal:  Histochem Cell Biol       Date:  2014-01-16       Impact factor: 4.304

8.  Marginal and joint distributions of S100, HMB-45, and Melan-A across a large series of cutaneous melanomas.

Authors:  Hollis Viray; William R Bradley; Kurt A Schalper; David L Rimm; Bonnie E Gould Rothberg
Journal:  Arch Pathol Lab Med       Date:  2013-08       Impact factor: 5.534

9.  ERβ splice variant expression in four large cohorts of human breast cancer patient tumors.

Authors:  Hallie Wimberly; Gang Han; Dushanthi Pinnaduwage; Leigh C Murphy; Xiaohong Rose Yang; Irene L Andrulis; Mark Sherman; Jonine Figueroa; David L Rimm
Journal:  Breast Cancer Res Treat       Date:  2014-07-10       Impact factor: 4.872

Review 10.  The nuclear envelope environment and its cancer connections.

Authors:  Kin-Hoe Chow; Rachel E Factor; Katharine S Ullman
Journal:  Nat Rev Cancer       Date:  2012-02-16       Impact factor: 60.716

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.